I-Mab Highlights Strategic Focus on Givastomig in Latest Financial Update
May 15, 2025 - 11:13
I-Mab has announced a strong commitment to advancing its lead program, givastomig, positioning the company for significant clinical progress. The latest data from a combination study involving givastomig has been selected for a mini-oral presentation at the upcoming ESMO GI conference, scheduled for July 2-5 in Barcelona, Spain. This recognition underscores the potential of givastomig in the oncology landscape.
As of March 31, 2025, I-Mab reported a robust financial standing, boasting $168.6 million in cash and cash equivalents, along with short-term investments. This solid financial foundation is expected to support the company’s operations and clinical endeavors well into 2027, particularly as it anticipates critical clinical readouts for givastomig in the near future.
The strategic prioritization of givastomig reflects I-Mab's focus on delivering innovative treatment options to patients while maintaining a strong financial outlook. The company remains committed to advancing its pipeline and achieving key milestones in the coming years.
MORE NEWS
June 18, 2026 - 00:10
Chairman Kevin Warsh: Financial markets work less efficiently when they consider what Fed thinksFederal Reserve Chairman Kevin Warsh argued on Wednesday that financial markets become less efficient when traders and investors spend too much time guessing what the central bank will do next....
June 17, 2026 - 02:28
City Council rejects first reading of budget, amendment approved to finance Ajax Turner non-profitThe City Council held its second first reading of the Fiscal Year budget on Tuesday night, but the outcome mirrored the previous session. Despite cutting more than $697,000 in proposed spending,...
June 16, 2026 - 22:13
'El Jefe' speaks: forget about 2008, it's really more like 2004The most senior chief financial officer among New York-listed companies has a message for investors who are bracing for a repeat of the 2008 financial crisis: calm down. According to the executive,...
June 16, 2026 - 07:40
RBA interest rate decision live: Aussies 'forced into hibernation' brace for year of painThe Reserve Bank of Australia has announced its latest cash rate decision, keeping interest rates on hold at 4.35 percent. The move was widely expected by economists, but it offers little relief...